晟德 (4123)
晟德 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$173.54M, up 33.3% from a year earlier. EPS over the last four quarters totals NT$1.34.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2003-10-07
- Founded
- 1959-11-04
- Paid-in capital
- NT$8.07B
- Common shares issued
- 807,456,341
- Legal name
- 晟德大藥廠股份有限公司
- Website
- https://www.centerlab.com.tw
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$173.54M | +15.0% | +33.3% |
| 2026-08 | NT$150.96M | -3.6% | +61.5% |
Year to date: +23.5% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -13.86 |
| 2026 Q1 | 2.62 |
| 2025 Q4 | 8.81 |
| 2025 Q3 | 3.77 |
| 2025 Q2 | -1.01 |
| 2025 Q1 | 0.76 |
| 2024 Q4 | -1.07 |
| 2024 Q3 | 0.40 |
Last four quarters: NT$1.34
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 1.75 | 0.50 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 13,215 | 0.4% |
| 1,000–5,000 shares | 21,264 | 5.8% |
| 5,001–10,000 shares | 5,516 | 4.7% |
| 10,001–15,000 shares | 2,507 | 3.7% |
| 15,001–20,000 shares | 1,069 | 2.2% |
| 20,001–30,000 shares | 1,232 | 3.6% |
| 30,001–40,000 shares | 626 | 2.6% |
| 40,001–50,000 shares | 320 | 1.8% |
| 50,001–100,000 shares | 678 | 5.7% |
| 100,001–200,000 shares | 310 | 5.2% |
| 200,001–400,000 shares | 136 | 4.8% |
| 400,001–600,000 shares | 44 | 2.5% |
| 600,001–800,000 shares | 22 | 1.9% |
| 800,001–1,000,000 shares | 18 | 2.0% |
| 1,000,001+ shares | 84 | 53.1% |
TDCC data for 2026-10-16: 84 holders own more than 1,000 lots (53.1% of shares), and 13,215 hold less than one lot (0.4%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -717 | 0 | 9 | -708 |
| 2026-10-16 | 264 | 0 | -60 | 204 |
| 2026-10-15 | 987 | 0 | -84 | 903 |
| 2026-10-14 | 213 | 0 | -1 | 212 |
| 2026-10-13 | -329 | 0 | -3 | -332 |
| 2026-10-12 | -36 | 0 | -86 | -122 |
| 2026-10-08 | 580 | 0 | -77 | 503 |
| 2026-10-07 | 378 | 0 | -34 | 344 |
| 2026-10-06 | 260 | 0 | -66 | 194 |
| 2026-10-05 | -92 | 0 | -104 | -196 |
| 2026-10-02 | -232 | 0 | -73 | -305 |
| 2026-10-01 | 17 | -31 | -64 | -78 |
| 2026-09-30 | 567 | 0 | -167 | 400 |
| 2026-09-29 | 430 | 0 | -25 | 405 |
| 2026-09-24 | -522 | 0 | -91 | -613 |
| 2026-09-23 | 512 | 0 | -177 | 335 |
| 2026-09-22 | 806 | 0 | -103 | 703 |
| 2026-09-21 | 141 | 0 | -31 | 110 |
| 2026-09-18 | 134 | 0 | -55 | 79 |
| 2026-09-17 | -38 | 0 | -119 | -157 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 1,881 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$30.05 (2026-10-19); 52-week range NT$29.35–51.40.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.